Back to search

Article

Single-cell-based evidence for GLS1 inhibitor as a bona fide senolytic agent in vivo

2025-07-23

Abstract excerpt

A plethora of senolytic compounds and technologies have been identified. However, the efficacy of these treatments in eliminating senescent cells and the suppression of chronic inflammation remains to be substantiated in vivo. Here, we employ single-cell RNA sequencing and find the selective elimination of highly inflammatory fibroblasts, endothelial cells in the lung, and proximal tubule cells in the kidney from...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a822b284-9354-5d0a-b204-76514fb0bd97
DOI
10.1101/2025.07.22.666220
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Single-cell-based evidence for GLS1 inhibitor as a bona fide senolytic agent in vivoDOI 10.1101/2025.07.22.666220
Select a neighboring publication to make it the new centre.